A detailed history of Morgan Stanley transactions in Qilian International Holding Group LTD stock. As of the latest transaction made, Morgan Stanley holds 1,794 shares of QLI stock, worth $5,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,794
Previous 1,794 -0.0%
Holding current value
$5,794
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.14 - $1.99 $2,280 - $3,980
-2,000 Reduced 52.71%
1,794 $2,000
Q2 2022

Oct 27, 2022

SELL
$1.4 - $2.0 $7,000 - $10,000
-5,000 Reduced 56.86%
3,794 $8,000
Q2 2022

Aug 15, 2022

SELL
$1.4 - $2.0 $7,000 - $10,000
-5,000 Reduced 56.86%
3,794 $8,000
Q1 2022

Oct 27, 2022

BUY
$1.57 - $2.68 $7,850 - $13,400
5,000 Added 131.79%
8,794 $15,000
Q3 2021

Nov 15, 2021

BUY
$3.92 - $4.35 $34,472 - $38,253
8,794 New
8,794 $36,000

Others Institutions Holding QLI

About Qilian International Holding Group Ltd


  • Ticker QLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 35,750,000
  • Market Cap $115M
  • Description
  • Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Ext...
More about QLI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.